Table 6.
Sensitivity of combined use of both CA125 and a panel of three anti–tumor‐associated antigen (TAAs).
Panel | CA125 | Total | |
---|---|---|---|
≥35 U/mL | <35 U/mL | ||
+ | 18 (A) | 34 (B) | 52 |
− | 23 (C) | 33 (D) | 56 |
Total | 41 | 67 | 108 |
Sensitivity (%) of CA125 = (A + C) / (A + B + C + D) = 41/108 = 37.96%.
Sensitivity (%) of a panel of three anti‐TAAs = (A + B)/ (A + B + C + D) = 52/108 = 48.15%.
Sensitivity (%) of combined both CA125 and a panel of three anti‐TAAs = (A + B + C)/ (A + B + C + D) = 75/108 = 69.44%.